Periodized Resistance Training for Persistent Non-specific Low Back Pain

Low Back Pain Clinical Trial

Official title:

Periodized Resistance Training for Persistent Non-specific Low Back Pain: A Mixed Methods Feasibility Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04284982
• Other study ID #: 2017/905
• Status: Completed
• Phase: N/A
• Start date: September 4, 2017
• Est. completion date: December 21, 2017

Study information

• Verified date: February 2020
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study the feasibility is investigated of a 16-week supervised heavy resistance training program with weekly undulating periodization for individuals with persistent non-specific low-back pain.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: December 21, 2017
• Est. primary completion date: December 21, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• persistent non-specific low back pain with a duration >3 months

• average low back pain intensity last two weeks >= 4 on numerical pain rating scale (0-10 scale)

• no experience with heavy resistance training.

Exclusion Criteria:

• previous surgery of the low back

• radiculopathy

• structural spinal changes and/or specific spinal conditions that limit function (spinal stenosis, ankylosing spondylitis, spondylolisthesis/spondylolysis, protrusion, structural scoliosis)

• autoimmune and systemic inflammatory diseases

• cardiovascular disease

• neurological diseases

• severe osteoporosis.

Related Conditions & MeSH terms

• Back Pain
• Low Back Pain

Intervention

Behavioral:
• 16-week supervised heavy resistance training program with weekly undulating periodization
Participants trained a whole-body program consisting of squat, bench press, deadlift and pendlay row two times per week for 16 weeks

Locations

Country	Name	City	State
Norway	Dept of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences	Trondheim

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Low back pain intensity on 0-10 Numerical Pain Rating Scale	From questionnaire: current pain, pain the last two weeks and pain the last four weeks, scale from 0-10 were 0 equals no pain and 10 equals the worst pain imaginable	8 weeks
Primary	Low back pain intensity on 0-10 Numerical Pain Rating Scale	From questionnaire: current pain, pain the last two weeks and pain the last four weeks, scale from 0-10 were 0 equals no pain and 10 equals the worst pain imaginable	16 weeks